Melanoma tumors switch to an alternative energy system when they develop resistance to chemotherapy, making that alternative system an attractive target for new treatments, according ...

With the goal of breaking the bottleneck in developing new drugs to treat Alzheimer’s disease, the National Institute of Aging will provide $25 million over ...

The OPTIMISTIC study, an innovative program developed and implemented by clinician-researchers from the Indiana University School of Medicine and the Regenstrief Institute to prevent unnecessary ...